Skip to main content
. Author manuscript; available in PMC: 2016 Oct 15.
Published in final edited form as: Cancer Res. 2015 Sep 10;75(20):4407–4415. doi: 10.1158/0008-5472.CAN-15-0888

Figure 1.

Figure 1

Synthesis and testing of MN-anti-miR10b. a. MN-anti-miR10b consisted of dextran-coated magnetic nanoparticles conjugated to an antisense LNA oligonucleotide targeting miRNA-10b. b. qRT-PCR showed significant inhibition of miRNA-10b, following a 48-hr incubation of human metastatic breast cancer cells with MN-anti-miR10b (Data represent average±s.d.; two-tailed t-test; n = 3).